Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
Abstract The objective of this study was to determine the proportion of phase 3 clinical trials investigating a systemic therapy for patients with prostate, breast, lung, or colorectal cancer that excluded patients with Chronic Kidney Disease (CKD) and the exclusion criteria chosen, if any. A search...
Saved in:
| Main Authors: | Matthieu Delaye, Adrien Rousseau, Mélanie Try, Christophe Massard, Luca Campedel, Marc Hilmi, Corinne Bagnis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges encountered to creating a renal biopsy program at a tertiary care academic institution in the United States
by: Eily Hayes, et al.
Published: (2025-12-01) -
Predictive value of machine learning model based on CT values for urinary tract infection stones
by: Jiaxin Li, et al.
Published: (2024-12-01) -
Accelerated Programs for High School Students: Dual Enrollment in Florida
by: Christina DiLorenzo, et al.
Published: (2023-06-01) -
Enrolment patterns in a randomized controlled trial of probiotics in critically ill patients: a retrospective analysis of the PROSPECT trial
by: Alyson Takaoka, et al.
Published: (2024-12-01) -
Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China
by: Bingbing Liu, et al.
Published: (2024-12-01)